Five decades of Fontan palliation: What have we learned? What should we expect?

被引:3
|
作者
Hassan, Adil [1 ]
Chegondi, Madhuradhar [2 ]
Porayette, Prashob [3 ]
机构
[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Stead Family Childrens Hosp, Div Pediat Crit Care Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Stead Family Childrens Hosp, Div Pediat Cardiol, Iowa City, IA 52242 USA
关键词
Single-ventricle physiology; Fontan; congenital heart disease; neurodevelopmental outcomes; adult congenital heart disease; arrhythmias; cyanosis; heart failure; cardiac transplantation; Fontan-associated liver disease; CONGENITAL HEART-DISEASE; PROTEIN-LOSING ENTEROPATHY; SINGLE VENTRICLE; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; AMERICAN-SOCIETY; VENOUS-PRESSURE; ARTERIAL DUCT; LONG-TERM; ADULTS;
D O I
10.1177/03000605231209156
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Fontan procedure is the final palliative surgery in a series of staged surgeries to reroute the systemic venous blood flow directly to the lungs, with the ventricle(s) pumping oxygenated blood to the body. Advances in medical and surgical techniques have improved patients' overall survival after the Fontan procedure. However, Fontan-associated chronic comorbidities are common. In addition to chronic cardiac dysfunction and arrhythmias, complications involving other organs such as the liver, lungs, intestine, lymphatic system, brain, and blood frequently occur. This narrative review focuses on the immediate and late consequences in children, pregnant women, and other adults with Fontan circulation. In addition, we describe the technical advancements that might change the way single-ventricle patients are managed in future.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] What have we learned about atrial arrhythmias from ablation of paroxysmal atrial fibrillation?
    Sawhney, Navinder
    Feld, Gregory K.
    HEART RHYTHM, 2008, 5 (06) : S32 - S35
  • [42] Development of human sonnatosensory cortical functions - what have we learned from magnetoencephalography: a review
    Nevalainen, Paivi
    Lauronen, Leena
    Pihko, Elina
    FRONTIERS IN HUMAN NEUROSCIENCE, 2014, 8
  • [43] Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not
    Argiro, Alessia
    Del Franco, Annamaria
    Mazzoni, Carlotta
    Allinovi, Marco
    Tomberli, Alessia
    Tarquini, Roberto
    Di Mario, Carlo
    Perfetto, Federico
    Cappelli, Francesco
    Zampieri, Mattia
    BIOMEDICINES, 2022, 10 (11)
  • [44] Successful COMPASS, Disappointing COMMANDER HF, What Have We Learned From These Two Trials?
    He, Yuhu
    Hu, Xinqun
    Zhou, Shenghua
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (04) : 306 - 307
  • [45] Oral appliances for obstructive sleep apnoea: What can we expect?
    Buiret, G.
    Chidiac, F.
    REVUE DES MALADIES RESPIRATOIRES, 2020, 37 (07) : 526 - 549
  • [46] Experience From Experimental Cell Transplantation Therapy of Myocardial Infarction: What Have We Learned?
    Dai, Wangde
    Kay, Gregory L.
    Jyrala, Aarne J.
    Kloner, Robert A.
    CELL TRANSPLANTATION, 2013, 22 (03) : 563 - 568
  • [47] Cardiohepatic syndrome What should we know as cardiologist?
    Guadalupe Baialardo, Antonela
    INSUFICIENCIA CARDIACA, 2015, 10 (02) : 66 - 77
  • [48] How should we advise heart failure patients on exercise and what should we tell them?
    Piotrowicz E.
    Orzechowski P.
    Chrapowicka A.
    Piotrowicz R.
    Current Heart Failure Reports, 2014, 11 (3) : 274 - 280
  • [49] Anthropogenically driven climate and landscape change effects on inland water carbon dynamics: What have we learned and where are we going?
    Pilla, Rachel M.
    Griffiths, Natalie A.
    Gu, Lianhong
    Kao, Shih-Chieh
    McManamay, Ryan
    Ricciuto, Daniel M.
    Shi, Xiaoying
    GLOBAL CHANGE BIOLOGY, 2022, 28 (19) : 5601 - 5629
  • [50] Congenital Heart Disease and the Athlete What We Know and What We Do Not Know
    Dean, Peter N.
    Battle, Robert W.
    CARDIOLOGY CLINICS, 2016, 34 (04) : 579 - +